“The future is already here. It’s just not evenly distributed.”William Gibson
The future of medicine, evenly distributed.
New medicines are already being made. We make sure patients in the places most trials never reach get access to them, and help shape them.
Trials go where the sites are, not where the patients are.
Most industry trials recruit in a handful of countries. Nigeria has more than 200 million people and 13 recruiting industry trials. The United States has 6,738. Large populations with capable hospitals and trained physicians are simply left out.
For sponsors this means slower enrollment and study populations that don’t reflect the patients who will use the drug. For patients it means no access to treatments that already exist.
Deja Clinical closes that gap. We help US and European sponsors and CROs bring in hospitals that aren’t in their site networks yet, and we support those sites’ own teams as they identify and enroll patients, with the compliance and data quality sponsors expect at home.
Every enrollment is a team effort
Research coordinators
We support each site’s research coordinators with training, study tools and day-to-day follow-up, so every visit runs to protocol.
Patients
Patients get access to new treatments, with consent and follow-up in their own language and a team that answers their questions.
Doctors and investigators
Local physicians lead the study at their own hospital. They identify, consent and treat their patients, supported by sponsor-grade processes and data systems.
What we do for sponsors and CROs
Patient feasibility
Send us a protocol synopsis. Together with site investigators, we estimate eligible patient numbers from their hospital data and flag the criteria that will slow enrollment.
Site identification
We work with university hospitals and specialist clinics outside the usual trial networks to find investigators with the right patients, experience and capacity for your study.
Recruitment support for sites
Recruitment stays with the site investigators and their teams. We give them tools to find eligible patients in their own records, AI-assisted and always reviewed by their clinicians, plus patient materials in local languages.
Data and compliance
ICH-GCP processes, data handling built to US and EU standards, and compliance with each country’s rules on biomedical research and personal data.
Common standards let good ideas travel.
A trial run at a new site should produce data a reviewer in Washington or Amsterdam can trust without a second look. We work to the same protocols, quality systems and data standards as your sites in the US and Europe.
Putting the data hospitals already collect to work
Hospitals outside the usual trial networks record diagnoses, treatments and outcomes every day. Captured to the same standards as your other sites, that data can serve more than one study, and larger pooled cohorts can answer questions that small ones can’t.
Every patient adds to the picture
Each person screened or enrolled at a new site brings in a population that global datasets are still missing.
Every trial sees beyond its own enrollment
Records from partner hospitals help with feasibility, comparison and long-term follow-up, including for patients outside the study arms.
Every next study starts further ahead
Each protocol we support leaves better baseline data for the one that comes after it.
From protocol to enrolled patients
Share your protocol
A synopsis and the key inclusion and exclusion criteria are enough to start, under NDA.
Get a feasibility report
Patient counts per site, candidate investigators, regulatory timeline and a recruitment plan.
Activate sites
We support submissions, contracts and site readiness with the hospitals and ethics committees.
Support and report
We support site teams through recruitment and follow-up, track enrollment and send regular reports to your study team.
New sites, same standards
Patients who are underrepresented
Large populations in Africa, the Middle East and beyond are barely present in global trial data. Including them strengthens your evidence and your submissions.
Run like your existing sites
We work to your timelines, protocols and systems, in English and French, so new sites join your study instead of running beside it.
Every language your patients speak
Consent, screening and follow-up in the patient’s own language, including local languages and dialects.
Need patients your current sites can’t reach?
Tell us about your study. We’ll reply with a first view of patient availability at sites outside your current network, at no cost.